Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Tuchman, SA"'
Autor:
Gertz M, Abonour R, Gibbs SN, Finkel M, Landau H, Lentzsch S, Lin G, Mahindra A, Quock T, Rosenbaum C, Rosenzweig M, Sidana S, Tuchman SA, Witteles R, Yermilov I, Broder MS
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 15, Pp 673-680 (2023)
Morie Gertz,1,* Rafat Abonour,2,* Sarah N Gibbs,3,* Muriel Finkel,4,* Heather Landau,5,* Suzanne Lentzsch,6,* Grace Lin,7,* Anuj Mahindra,8,* Tiffany Quock,9,* Cara Rosenbaum,10,* Michael Rosenzweig,11,* Su
Externí odkaz:
https://doaj.org/article/5caae92b3e3441049a5da69583d649e9
Autor:
Dupuis MM, Tuchman SA
Publikováno v:
OncoTargets and Therapy, Vol Volume 9, Pp 7583-7590 (2016)
Megan Murray Dupuis,1 Sascha A Tuchman2 1Department of Medicine, Duke University, Durham, 2Division of Hematology/Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA Abstract: Multiple m
Autor:
Prytula, Agnieszka, Iijima, K, Kamei, K, Geary, D, Gottlich, E, Majeed, A, Taylor, M, Marks, S, Tuchman, SA, Camilla, R, Ognjanovic, M, Filler, G, Smith, G, Tullus, K
Publikováno v:
Pediatric Nephrology, 25, 461-468. Springer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::0d9c29f5c2b79bb7e48c11b80a336ff0
https://pure.eur.nl/en/publications/91e32128-b3d4-4842-94fe-57f280cc794b
https://pure.eur.nl/en/publications/91e32128-b3d4-4842-94fe-57f280cc794b
Autor:
Rao, AV, Valk, Peter, Metzeler, KH, Acharya, CR, Tuchman, SA, Stevenson, MM, Rizzieri, DA, Delwel, Ruud, Buske, C, Bohlander, SK, Potti, A, Löwenberg, Bob
Publikováno v:
Journal of Clinical Oncology, 27(33), 5580-5586. American Society of Clinical Oncology
Purpose To define the biology driving the aggressive nature of acute myeloid leukemia (AML) in elderly patients. Patients and Methods Clinically annotated microarray data from 425 patients with newly diagnosed de novo AML from two publicly available
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::f6db13c4b1f47c9d85ce05acac94070c
https://pure.eur.nl/en/publications/ef1e4493-a50f-486b-a62b-f1a06fbacca7
https://pure.eur.nl/en/publications/ef1e4493-a50f-486b-a62b-f1a06fbacca7
Autor:
Anguiano A, Tuchman SA, Acharya C, Salter K, Gasparetto C, Zhan F, Dhodapkar M, Nevins J, Barlogie B, Shaughnessy JD Jr, Potti A, Anguiano, Ariel, Tuchman, Sascha A, Acharya, Chaitanya, Salter, Kelly, Gasparetto, Cristina, Zhan, Fenghuang, Dhodapkar, Madhav, Nevins, Joseph, Barlogie, Bart
Publikováno v:
Journal of Clinical Oncology; 9/1/2009, Vol. 27 Issue 25, p4197-4203, 7p
Autor:
LeBlanc MR; University of North Carolina at Chapel Hill School of Nursing, Chapel Hill, North Carolina, USA; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA. Electronic address: matthew_leblanc@unc.edu., Zhou X; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA., Baggett CD; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA., Tuchman SA; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA; University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA., Jensen CE; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA; University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA., Lichtman EI; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA; University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA., Rubinstein SM; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA; University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Sep; Vol. 24 (9), pp. 611-620. Date of Electronic Publication: 2024 Apr 19.
Autor:
Jensen CE; Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Physicians Office Building, CB# 7305, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, Chapel Hill, NC 27599, USA. Electronic address: christopher.jensen@unchealth.unc.edu., Deal AM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, Chapel Hill, NC 27599, USA. Electronic address: allison_deal@med.unc.edu., Nyrop KA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, Chapel Hill, NC 27599, USA; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Physicians Office Building, CB# 7305, Chapel Hill, NC 27599, USA. Electronic address: kirsten_nyrop@med.unc.edu., Logan M; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, Chapel Hill, NC 27599, USA. Electronic address: mayal99@live.unc.edu., Mangieri NJ; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, Chapel Hill, NC 27599, USA. Electronic address: nicholas_mangieri@med.unc.edu., Strayhorn MD; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, Chapel Hill, NC 27599, USA. Electronic address: dell_strayhorn@med.unc.edu., Miller J; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, Chapel Hill, NC 27599, USA. Electronic address: jordan.miller@unchealth.unc.edu., Muss HB; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, Chapel Hill, NC 27599, USA; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Physicians Office Building, CB# 7305, Chapel Hill, NC 27599, USA. Electronic address: hyman_muss@med.unc.edu., Lichtman EI; Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Physicians Office Building, CB# 7305, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, Chapel Hill, NC 27599, USA. Electronic address: eben_lichtman@med.unc.edu., Rubinstein SM; Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Physicians Office Building, CB# 7305, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, Chapel Hill, NC 27599, USA. Electronic address: samuel_rubinstein@med.unc.edu., Tuchman SA; Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Physicians Office Building, CB# 7305, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, Chapel Hill, NC 27599, USA. Electronic address: sascha_tuchman@med.unc.edu.
Publikováno v:
Journal of geriatric oncology [J Geriatr Oncol] 2024 Mar; Vol. 15 (2), pp. 101680. Date of Electronic Publication: 2023 Dec 16.
Autor:
Schiller GJ; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA. Electronic address: gschiller@mednet.ucla.edu., Lipe BC; University of Rochester, Rochester, NY., Bahlis NJ; Charbonneau Cancer Research Institute, Calgary, AB, Canada; Clinical Research Unit, Tom Baker Cancer Center, Calgary, AB, Canada., Tuchman SA; University of North Carolina, Chapel Hill, NC., Bensinger WI; Swedish Cancer Institute, Seattle, WA., Sutherland HJ; Vancouver General Hospital, Vancouver, BC, Canada., Lentzsch S; Multiple Myeloma and Amyloidosis Service, Columbia University, New York, NY., Baljevic M; Vanderbilt University Medical Center, Nashville, TN., White D; Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada., Kotb R; CancerCare Manitoba, Winnipeg, MB, Canada., Chen CI; Princess Margaret Cancer Centre, Toronto, ON, Canada., Rossi A; Weill Cornell Medicine, New York, NY., Biran N; Hackensack Meridian Health, Hackensack University Medical Center, Hackensack, NJ., LeBlanc R; Maisonneuve-Rosemont Hospital, University of Montreal, QC, Canada., Grosicki S; Department of Hematology and Cancer Prevention, Medical University of Silesia, Katowice, Poland., Martelli M; Department of Cellular Biotechnology and Hematology, Hematology Center, Umberto I Polyclinic of Rome, Rome, Italy., Gunsilius E; Department of Internal Medicine V, Medical University Innsbruck, Innsbruck, Austria., Špička I; First Department of Medicine - Department of Hematology, First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic., Stevens DA; Norton Cancer Institute, St. Matthews Campus, Louisville, KY., Facon T; Department of Hematology (Maladies du sang), Hôpital Huriez, CHU, Lille, France., Mesa MG; Department of Hematology, Vall d'Hebron University Hospital, Barcelona, Spain., Zhang C; Karyopharm Therapeutics Inc., Newton, MA., Van Domelen DR; Karyopharm Therapeutics Inc., Newton, MA., Bentur OS; Karyopharm Therapeutics Inc., Newton, MA., Gasparetto C; Duke University Cancer Center, Durham, NC.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2023 Sep; Vol. 23 (9), pp. e286-e296.e4. Date of Electronic Publication: 2023 Jun 05.
Autor:
Grant SJ; Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC.; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Jansen M; University Libraries, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Kuo TM; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Rubinstein SM; Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC.; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Wildes TM; Division of Hematology and Oncology, Department of Medicine, University of Nebraska Medical Center, Omaha, NE., Tuchman SA; Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC.; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Muss HB; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC.; Division of Medical Oncology, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Lichtman EI; Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC.; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Charlot M; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC.; Division of Medical Oncology, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2023 Feb; Vol. 19 (2), pp. e248-e262. Date of Electronic Publication: 2022 Dec 06.
Autor:
Kang Y; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, 2400 Pratt Street, Suite 5000, Durham, NC, DUMC 396127710, USA. yubin.kang@duke.edu., Sundaramoorthy P; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, 2400 Pratt Street, Suite 5000, Durham, NC, DUMC 396127710, USA., Gasparetto C; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, 2400 Pratt Street, Suite 5000, Durham, NC, DUMC 396127710, USA., Feinberg D; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, 2400 Pratt Street, Suite 5000, Durham, NC, DUMC 396127710, USA., Fan S; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, 2400 Pratt Street, Suite 5000, Durham, NC, DUMC 396127710, USA., Long G; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, 2400 Pratt Street, Suite 5000, Durham, NC, DUMC 396127710, USA., Sellars E; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, 2400 Pratt Street, Suite 5000, Durham, NC, DUMC 396127710, USA., Garrett A; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, 2400 Pratt Street, Suite 5000, Durham, NC, DUMC 396127710, USA., Tuchman SA; Division of Hematology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Reeves BN; Division of Hematology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Li Z; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA., Liu B; Division of Hematology, Department of Internal Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Ogretmen B; Department of Biochemistry and Molecular Biology, and Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA., Maines L; Apogee Biotechnology Corporation, Hummelstown, PA, USA., Ben-Yair VK; RedHill Biopharma, Tel Aviv, Israel., Smith C; Apogee Biotechnology Corporation, Hummelstown, PA, USA., Plasse T; RedHill Biopharma, Tel Aviv, Israel.
Publikováno v:
Annals of hematology [Ann Hematol] 2023 Feb; Vol. 102 (2), pp. 369-383. Date of Electronic Publication: 2022 Dec 03.